Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

SBIR grant received by Acorda for spinal cord injury regeneration research

Sep. 5, 2001

Pyrazolopyridine adenosine A1 antagonist selected for further development at Fujisawa

Sep. 4, 2001

Cephalon reports changes in Gabitril product name

Sep. 4, 2001

Neuromuscular blockade reversed by cyclodextrin-based compounds

Sep. 3, 2001

Potential new antidepressants described at ACS meeting: AMPA receptor potentiators

Sep. 3, 2001

Nippon Kayaku withdraws central muscle relaxant from approval process

Sep. 3, 2001

Novel adenosine kinase inhibitors with improved half-life and oral bioavailability

Sep. 3, 2001

FDA accepts Orphan Medical's proposed response plan regarding Xyrem NDA

Sep. 3, 2001

Devacade shown to enhance pain relief in phase II clinical trial

Sep. 3, 2001

Selective GABA-A alpha5 ligands reported by Merck

Aug. 31, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.